Nykode Therapeutics AS (OSL: NYKD)
Norway
· Delayed Price · Currency is NOK 3.020
+0.132 (4.57%)
Dec 23, 2024, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 986.17 million as of December 27, 2024. Its market cap has decreased by -83.22% in one year.
Market Cap
986.17M
Enterprise Value
-278.22M
Revenue
46.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.02
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 986.17M, a decrease of -82.15%. That is a compound annual growth rate of -29.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2024 | 986.17M | -85.89% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 3.15B |
| Medistim ASA | 2.75B |
| Photocure ASA | 1.73B |
| Carasent ASA | 1.53B |
| ArcticZymes Technologies ASA | 684.36M |
| Hofseth BioCare ASA | 657.73M |
| Thor Medical ASA | 624.73M |
| Gentian Diagnostics ASA | 619.98M |